港股异动 | 艾美疫苗(06660)现涨超5% 公司拟申请在北交所上市全球首款无血清狂苗上市在即

智通财经04-15

智通财经APP获悉，艾美疫苗(06660)现涨超5%，截至发稿，涨5.17%，报3.05港元，成交额940.29万港元。消息面上，3月30日，艾美疫苗董事会审议通过：拟增发不超过4000万股内资股，不超过本次发行前公司已发行股份总数的约3.2611%，并计划推动内资股在全国股转系统挂牌，进一步申请在北京证券交易所上市。公开资料显示，艾美疫苗共20款在研疫苗，拥有24个临床批件，公司正在稳步推动...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2627440658?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-15 14:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2627440658","market":"fut","top_or_hot":-1,"title":"港股异动 | 艾美疫苗(06660)现涨超5% 公司拟申请在北交所上市 全球首款无血清狂苗上市在即","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，艾美疫苗(06660)现涨超5%，截至发稿，涨5.17%，报3.05港元，成交额940.29万港元。消息面上，3月30日，艾美疫苗董事会审议通过：拟增发不超过4000万股内资股，不超过本次发行前公司已发行股份总数的约3.2611%，并计划推动内资股在全国股转系统挂牌，进一步申请在北京证券交易所上市。公开资料显示，艾美疫苗共20款在研疫苗，拥有24个临床批件，公司正在稳步推动...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1428730.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 艾美疫苗(06660)现涨超5% 公司拟申请在北交所上市 全球首款无血清狂苗上市在即</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 艾美疫苗(06660)现涨超5% 公司拟申请在北交所上市 全球首款无血清狂苗上市在即\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-15 14:53 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1428730.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，艾美疫苗(06660)现涨超5%，截至发稿，涨5.17%，报3.05港元，成交额940.29万港元。消息面上，3月30日，艾美疫苗董事会审议通过：拟增发不超过4000万股内资股，不超过本次发行前公司已发行股份总数的约3.2611%，并计划推动内资股在全国股转系统挂牌，进一步申请在北京证券交易所上市。公开资料显示，艾美疫苗共20款在研疫苗，拥有24个临床批件，公司正在稳步推动...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1428730.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06660","symbol_name":"艾美疫苗","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1428730.html","article_id":"2627440658","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2627440658","pubTimestamp":1776236029,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，艾美疫苗现涨超5%，截至发稿，涨5.17%，报3.05港元，成交额940.29万港元。消息面上，3月30日，艾美疫苗董事会审议通过：拟增发不超过4000万股内资股，不超过本次发行前公司已发行股份总数的约3.2611%，并计划推动内资股在全国股转系统挂牌，进一步申请在北京证券交易所上市。公开资料显示，艾美疫苗共20款在研疫苗，拥有24个临床批件，公司正在稳步推动产品线布局。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"06660":"艾美疫苗","BK4588":"碎股","VXUS":"国际股票ETF-Vanguard","BK1161":"生物科技","BK4585":"ETF&股票定投概念","IPOS":"Renaissance International IPO ETF"},"translate_title":"Changes in Hong Kong stocks | Aimei vaccine (06660) has risen by more than 5%. The company plans to apply for listing on the Beijing Stock Exchange. The world's first serum-free crazy vaccine is about to be listed","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VXUS":1.5,"IPOS":1.5,"06660":1.5},"content_text":"智通财经APP获悉，艾美疫苗(06660)现涨超5%，截至发稿，涨5.17%，报3.05港元，成交额940.29万港元。消息面上，3月30日，艾美疫苗董事会审议通过：拟增发不超过4000万股内资股，不超过本次发行前公司已发行股份总数的约3.2611%，并计划推动内资股在全国股转系统挂牌，进一步申请在北京证券交易所上市。公开资料显示，艾美疫苗共20款在研疫苗，拥有24个临床批件，公司正在稳步推动产品线布局。今年1月，公司全球首研的无血清迭代狂犬疫苗已顺利通过药物临床试验现场检查，及药品注册生产现场检查；目前全球市场上尚未有无血清狂犬疫苗获批上市，该产品上市后有望弥补市场空白。另外，23价肺炎多糖疫苗、新型工艺高效价人二倍体狂犬疫苗等多款重磅大单品也已都即将进入收获期。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2627440658","isCrawlerRequest":true}

港股异动 | 艾美疫苗(06660)现涨超5% 公司拟申请在北交所上市 全球首款无血清狂苗上市在即

精彩评论

港股异动 | 艾美疫苗(06660)现涨超5% 公司拟申请在北交所上市全球首款无血清狂苗上市在即